REC-64151

N/A

Report date: 2023/03/05 18:10:19
NME

Base Information

Drug NameREC-64151
Drug Alias NameREC-64151
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase STK11 inhibitorsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsSerine/threonine-protein kinase STK11GTPase KRas
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecursion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A